New Journey Health Technology Group Co.,LTD (SHE:002219)

SHE:002219 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	7,228	7,194	8,916	10,335	12,861	6,827
Market Cap Growth	-7.35%	-19.32%	-13.72%	-19.64%	88.39%	106.78%
Enterprise Value	9,416	8,441	10,339	11,320	12,997	8,228
Last Close Price	2.10	2.13	2.64	3.03	3.94	3.66

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	225.47	232.49	77.69	356.71	82.38	-
Forward PE	-	59.75	59.75	59.75	59.75	59.75
PS Ratio	2.52	2.36	2.35	2.64	4.07	2.26
PB Ratio	3.55	3.58	4.37	4.76	7.28	4.30
P/TBV Ratio	15.34	16.24	19.18	17.58	22.43	17.17
P/FCF Ratio	271.60	195.58	68.03	92.90	276.78	86.89
P/OCF Ratio	33.02	24.49	20.33	32.20	47.98	24.62
PEG Ratio	-	3.52	3.52	3.52	3.52	3.52

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
EV/Sales Ratio	3.28	2.77	2.72	2.89	4.11	2.73
EV/EBITDA Ratio	24.64	23.64	21.52	29.43	33.68	64.65
EV/EBIT Ratio	45.24	41.22	33.65	64.00	56.53	-
EV/FCF Ratio	353.82	229.49	78.88	101.75	279.72	104.73

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Debt / Equity Ratio	1.23	0.95	0.97	1.11	0.73	1.23
Debt / EBITDA Ratio	6.53	4.86	3.77	5.79	3.25	15.29
Debt / FCF Ratio	93.80	51.78	15.04	21.61	27.72	24.86
Net Debt / Equity Ratio	1.05	0.75	0.73	0.83	0.41	-0.05
Net Debt / EBITDA Ratio	6.11	4.22	3.11	4.69	1.89	-0.63
Net Debt / FCF Ratio	79.96	41.01	11.39	16.20	15.68	-1.02
Asset Turnover	0.43	0.46	0.57	0.64	0.51	0.52
Inventory Turnover	11.31	12.31	12.20	13.92	12.34	12.15
Quick Ratio	0.48	0.49	0.50	0.52	0.44	0.60
Current Ratio	0.55	0.54	0.57	0.59	0.54	0.66
Return on Equity (ROE)	1.72%	1.65%	5.71%	2.02%	9.84%	-42.13%
Return on Assets (ROA)	1.95%	1.92%	2.89%	1.80%	2.33%	-0.39%
Return on Invested Capital (ROIC)	2.15%	2.49%	6.39%	5.47%	10.11%	-2.17%
Return on Capital Employed (ROCE)	6.70%	6.60%	9.80%	5.60%	9.90%	-1.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Earnings Yield	0.42%	0.43%	1.29%	0.28%	1.21%	-5.44%
FCF Yield	0.37%	0.51%	1.47%	1.08%	0.36%	1.15%
Payout Ratio	306.58%	325.46%	103.03%	366.45%	176.67%	-
Buyback Yield / Dilution	-4.24%	-0.10%	-1.02%	0.33%	-75.08%	0.02%

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error